Accès gratuit
Numéro
Le Nouveau Praticien Vét canine & féline
Volume 19, Numéro 82, Décembre 2022
Affections des surrénales chez le chat, le chien et le furet
Page(s) 20 - 24
Section Dossier : Affections surrénales du chien, du chat et du furet
DOI https://doi.org/10.1051/npvcafe/2022070
Publié en ligne 6 février 2023
  • Cho KD, Kang JH, Chang D, et coll. Efficacy of low and high-dose trilostane treatment in dogs (< 5 kg) with pituitary-dependent hyperadrenocorticism. J Vet Intern Med. 2013;27:91–8. [CrossRef] [PubMed] [Google Scholar]
  • Feldman EC, Kass PH. Trilostane dose versus body weight in the treatment of naturally occurring pituitary-dependent hyperadrenocorticism in dogs. J Vet Intern Med. 2012;26:1078–80. [CrossRef] [PubMed] [Google Scholar]
  • Arenas C, Melian C, Perez-Alenza MD. Evaluation of 2 trilostane protocols for the treatment of canine pituitary-dependent hyperadrenocorticism: Twice daily versus once daily. J Vet Intern Med. 2013;27:1478–85. [CrossRef] [PubMed] [Google Scholar]
  • Feldman EC. Evaluation of twice-daily lower-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism. J Am Vet Med Assoc. 2011;238:1441–51. [CrossRef] [PubMed] [Google Scholar]
  • Lemetayer J, Blois S. Update on the use of trilostane in dogs. Can Vet J. 2018;59:397–407. [PubMed] [Google Scholar]
  • King JB, Morton JM. Incidence and risk factors for hypoadrenocorticism in dogs treated with trilostane. Vet J. 2017;230:24–9. [CrossRef] [PubMed] [Google Scholar]
  • Burkhardt WA, Boretti FS, Reusch CE, et coll. Evaluation of baseline cortisol, endogenous ACTH, and cortisol/ACTH ratio to monitor trilostane treatment in dogs with pituitary-dependent hypercortisolism. J Vet Intern Med. 2013;27:919–23. [CrossRef] [PubMed] [Google Scholar]
  • Nagata N, Kojima K, Yuki M. Comparison of survival times for dogs with pituitary-dependent hyperadrenocorticism in a primary-care hospital: treated with trilostane versus untreated. J Vet Intern Med. 2017;31:22–8. [CrossRef] [PubMed] [Google Scholar]
  • Bonadio CM, Feldman EC, Cohen TA, et coll. Comparison of adrenocorticotropic hormone stimulation test results started 2 versus 4 hours after trilostane administration in dogs with naturally occurring hyperadrenocorticism. J Vet Intern Med. 2014;28:1239–43. [CrossRef] [PubMed] [Google Scholar]
  • Griebsch C, Lehnert C, Williams GJet coll. Effect of trilostane on hormone and serum electrolyte concentrations in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med. 2014;28:160–5. [CrossRef] [PubMed] [Google Scholar]
  • Arenas Bermejo C, Pérez Alenza D, García San José P., et coll. Laboratory assessment of trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med. 2020;34:1413–22. [CrossRef] [PubMed] [Google Scholar]
  • Boretti FS, Holzthuem J, Reusch CE, et coll. Lack of association between clinical signs and laboratory parameters in dogs with hyperadrenocorticism before and during trilostane treatment. Schweizer Archiv für Tierheilkunde. 2016;158:631–8. [CrossRef] [PubMed] [Google Scholar]
  • Golinelli S, de Marco V, Leal RO, et coll. Comparison of methods to monitor dogs with hypercortisolism treated with trilostane. J Vet Intern Med. 2021;35:2616–27. [CrossRef] [PubMed] [Google Scholar]
  • Macfarlane L, Parkin T, Ramsey I. Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs. Vet Rec. 2016;179(23):597. [CrossRef] [PubMed] [Google Scholar]
  • Midence JN, Drobatz KJ, Hess RS. Cortisol concentrations in well-regulated dogs with hyperadrenocorticism treated with trilostane. J Vet Intern Med. 2015;29(6):1529–33. [CrossRef] [PubMed] [Google Scholar]
  • Ramsey IL, Fracassi F, Galac S, et coll. The repeatability of various cortisol measurements in clinically stable dogs with hyperadrenocorticism being treated with trilostane. ECVIM Congress (abstract), , 2016. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.